UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...

Enphase Energy started shipping its IQ9N-3P Commercial Microinverter across the United States in late December 2025. The ...

See what moon phase it is tonight and find out when you can see the rest of the moon phases for 2026. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it ...

U.S. nuclear power is seeing a resurgence as utilities, tech companies, and federal programs invest in restarts, SMRs, and next-generation reactors to meet growing demand and ... Wildfire risk ...